Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "Emergent"
showing the first 40- Emergent BioSolutions Inc. (EBS)10-K · 2009-03-06Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)S-1 · 2006-08-14Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-12B/A · 2016-06-29Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-Q · 2010-05-06Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-Q · 2008-05-07Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)8-K · 2016-08-02Read the filing on SEC.gov →
- SAB Biotherapeutics, Inc.8-K · 2026-05-04Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-K · 2018-03-13Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-Q · 2008-08-07Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-12B/A · 2016-06-29Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-Q · 2010-08-06Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-Q · 2012-05-04Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-Q · 2016-08-05Read the filing on SEC.gov →
- Trubion Pharmaceuticals, Inc425 · 2010-08-13Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-K · 2016-02-29Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)S-1 · 2006-08-14Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-12B · 2016-04-15Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)8-K · 2016-08-02Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)S-1/A · 2006-10-20Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-K · 2016-02-29Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-K · 2020-02-25Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-12B/A · 2016-06-29Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-K · 2022-02-25Read the filing on SEC.gov →
- EMERGENT CAPITAL, INC.8-K · 2020-10-15Read the filing on SEC.gov →
- EMERGENT GROUP INC/NYS-4 · 2001-04-12Read the filing on SEC.gov →
- KAMADA LTD (KMDA)20-F · 2023-03-15Read the filing on SEC.gov →
- Liminal BioSciences Inc.20-F · 2020-03-20Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-12B/A · 2016-06-29Read the filing on SEC.gov →
- EMERGENT GROUP INC/NYSC TO-T/A · 2011-03-25Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-Q · 2008-11-07Read the filing on SEC.gov →
- EMERGENT GROUP INC/NY10-K · 2003-01-30Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-K · 2010-03-05Read the filing on SEC.gov →
- EMERGENT GROUP INC/NYSC 14D9/A · 2011-03-09Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-K · 2025-03-04Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)S-1 · 2006-08-14Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)S-1 · 2006-08-14Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-12B · 2016-04-15Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-K · 2018-03-13Read the filing on SEC.gov →
- Aptevo Therapeutics Inc. (APVO)10-12B · 2016-04-15Read the filing on SEC.gov →
- Emergent BioSolutions Inc. (EBS)10-K · 2026-02-27Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001 onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.